Search for: "Merial Inc"
Results 21 - 40
of 50
Sorted by Relevance
|
Sort by Date
14 Aug 2009, 12:35 am
"Intervet, Inc. v. [read post]
26 Feb 2010, 4:17 pm
Merial L.L.C. et al; Simonian v. [read post]
4 Dec 2013, 7:06 am
Merial Ltd. v. [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging… [read post]
8 May 2020, 11:00 am
”[1] Merial Ltd. v. [read post]
25 Mar 2020, 3:00 pm
” Merial Ltd. v. [read post]
23 Dec 2009, 12:40 am
: Proposed amendments to Plant Variety Statute (IP Osgoode) EU: German Federal Supreme Court referral to ECJ concerning embryonic stem cells and the Biotech Directive (EPLAW) EU: Data exclusivity and food claims in Europe - Commission authorises health claim on the effect of water-soluble tomato concentrate on platelet aggregation and grants protection of proprietary data under Regulation (EC) No 1924/2006 (IPKat) France: Pharma trade marks under threat - Senate and National Assembly approve law… [read post]
5 Sep 2016, 6:46 pm
Merial. [read post]
26 Sep 2010, 7:29 pm
The appellate case was Intervet Inc. v. [read post]
24 Apr 2016, 7:00 am
Grp., Inc., 149 F.3d 1368 (Fed. [read post]
18 Aug 2010, 12:19 am
Merial Ltd. [read post]
18 Sep 2016, 6:03 pm
Merial L.L.C., et al., No. 16-188 (Sequenom redux; also question whether ineligibility is a proper subject of a motion to dismiss on the pleadings) Eligibility: Essociate, Inc. v. [read post]
12 Jan 2011, 8:26 am
Merial Ltd., 2010 U.S. [read post]
12 Jan 2011, 8:26 am
Merial Ltd., 2010 U.S. [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
8 Feb 2017, 3:09 am
AKM Enterprise, Inc., dba Moblize, Inc. [read post]
16 Jan 2017, 5:44 pm
: Big Baboon, Inc. v. [read post]
14 Nov 2016, 9:16 am
Pharmatech Solutions, Inc., No. 16-377 Design Patents: Systems, Inc. v. [read post]
28 Sep 2016, 8:39 am
Merial L.L.C., et al., No. 16-188 (Sequenom redux; also question whether ineligibility is a proper subject of a motion to dismiss on the pleadings) Eligibility: Essociate, Inc. v. [read post]
